AbbVie and Mission in Neurological R&D Pact

26.11.2018 - US biopharma AbbVie has signed a deal with UK drug discovery and development group Mission Therapeutics to develop specific deubiquitylating enzymes (DUBs) for treating Alzheimer’s...